Cytokinetics (CYTK) Operating Margin (2016 - 2025)
Historic Operating Margin for Cytokinetics (CYTK) over the last 16 years, with Q4 2024 value amounting to 1555.61%.
- Cytokinetics' Operating Margin rose 91763000.0% to 1555.61% in Q4 2024 from the same period last year, while for Dec 2024 it was 7255.42%, marking a year-over-year increase of 138451300.0%. This contributed to the annual value of 1422.37% for FY2024, which is 80120800.0% up from last year.
- According to the latest figures from Q4 2024, Cytokinetics' Operating Margin is 1555.61%, which was up 91763000.0% from 30410.58% recorded in Q3 2024.
- Over the past 5 years, Cytokinetics' Operating Margin peaked at 1555.61% during Q4 2024, and registered a low of 52277.91% during Q2 2024.
- Its 5-year average for Operating Margin is 8792.85%, with a median of 2312.87% in 2023.
- Within the past 5 years, the most significant YoY rise in Cytokinetics' Operating Margin was 91763000bps (2024), while the steepest drop was -382007500bps (2024).
- Cytokinetics' Operating Margin (Quarter) stood at 288.81% in 2020, then tumbled by -119bps to 54.16% in 2021, then plummeted by -11884bps to 6491.06% in 2022, then decreased by -17bps to 7620.69% in 2023, then skyrocketed by 120bps to 1555.61% in 2024.
- Its Operating Margin was 1555.61% in Q4 2024, compared to 30410.58% in Q3 2024 and 52277.91% in Q2 2024.